Financial Reporting
Page 1 • 2 itemsGain critical insights into global pharma financial reporting, M&A trends, and investment analysis. Drive strategic decisions with expert intelligence.
Amgen Reports Strong Q1 2026 Financial Results with 16 Brands Achieving Double-Digit Growth
Amgen's Q1 2026 results show robust performance with 16 brands posting double-digit growth, offsetting patent expirations and increased competition.
Zhengye Biotechnology Reports Fiscal 2025 Financial Results for Veterinary Vaccine Business
Zhengye Biotechnology (NASDAQ: ZYBT) announces fiscal year 2025 financial results, highlighting performance in veterinary vaccine manufacturing and research operations.